Skip to content

SERB

Active
Public limited company·Groothandel in farmaceutische en medische artikelen· 12 yrs active
Louizalaan 480 ·1050 Elsene, Belgium
KBO/BCE: BE 0538.813.719
Watch Print / PDF
Full dossier in preparation

Checked processes every Belgian company, act by act, from the Belgian Official Gazette. The data below is real and verified, this company's full, act-by-act verified dossier is still being assembled.

Process with priority Sign in free to move this company to the front.
Age12 yrs
Board3
Real estate1 parcel · 2,791 m²

Summary

Conclusion

the dossier summarised in one paragraph

The computed 12-month bankruptcy probability of SERB is 1.0% (low). The company has been active since 2013 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.

Based on State Gazette and CBE data.

Filing behaviour

From the deposit records, complete market-wide
Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 08-06-2026, 53 days ahead of the deadline. This speaks to administrative punctuality and says nothing about the financial position.
The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
How we compute the deadline
The year end is derived from 10 filed financial years, each closing on 31-12. The statutory deadline is seven months after the close of the financial year (art. 3:10 par. 1 CAC, art. 3:47 par. 7 for ASBL and foundations). Applied to the financial year that closed on 31-12-2025, that is 31-07-2026.
Deadline per financial year
Year closed Due by Filed Variance Reference
31-12-2025 31-07-2026 08-06-2026 53 d early 2026-00143236
31-12-2024 31-07-2025 04-11-2025 96 d late 2025-00561139
31-12-2023 31-07-2024 13-06-2024 48 d early 2024-00139491
31-12-2022 31-07-2023 06-06-2023 55 d early 2023-00112428
31-12-2021 31-07-2022 14-07-2022 17 d early 2022-20208642
31-12-2020 31-07-2021 12-08-2021 12 d late 2021-49000259
31-12-2019 31-07-2020 28-07-2020 3 d early 2020-36100596
31-12-2018 31-07-2019 29-08-2019 29 d late 2019-56200051
31-12-2017 31-07-2018 16-07-2018 15 d early 2018-34500331
31-12-2016 31-07-2017 27-06-2017 34 d early 2017-23200419

Source: the National Bank's deposit records. Those records are complete, including for years whose figures we have not read yet. Filing late covers nearly half the market and is therefore not scored; only not filing, being more than 90 days late and breaking a punctual record carry weight.

Trust signals

2 signals
Established
Founded in 2013, 12 years in business.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.

Administrative Flags

No strikeouts found in the KBO publications we processed. That series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.

Bankruptcy probability (12 mo)

Checked model v1 · free for everyone
1.0% Low
0%0,5%1,5%4%10%≥25%
Higher-failure-rate region +Lower-risk legal form −Higher-failure-rate sector +

Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?

Financials

Annual accounts & ratios

Source: NBB
Financials being processed
NBB has 10 filing(s) on record for this company, latest fiscal year 2025 (volledig). The annual accounts are being processed.
Filings on record
Fiscal year Type Filed Reference
31-12-2025 volledig 08-06-2026 2026-00143236
31-12-2024 volledig 04-11-2025 2025-00561139
31-12-2023 volledig 13-06-2024 2024-00139491
31-12-2022 volledig 06-06-2023 2023-00112428
31-12-2021 volledig 14-07-2022 2022-20208642
31-12-2020 volledig 12-08-2021 2021-49000259
31-12-2019 volledig 28-07-2020 2020-36100596
31-12-2018 volledig 29-08-2019 2019-56200051
31-12-2017 volledig 16-07-2018 2018-34500331
31-12-2016 volledig 27-06-2017 2017-23200419

Directors

Directors & mandates

13 directors
Current directors & mandates
  • Marc BUCHET
    Director
    State Gazette act 24105873 (15-07-2024)
    Current
    15-07-2024 → present
    2 events
    • 15-07-2024 Appointed· Director
    • 15-07-2024 Appointed· Managing director
  • Antoine Bernasconi
    Administrator
    State Gazette act 23093417 (20-07-2023)
    Current
    20-07-2023 → present
  • Bich Pham Huy
    Administrator
    State Gazette act 23093417 (20-07-2023)
    Current
    20-07-2023 → present
Historic, not recently confirmed (4)
These mandates remain open in the register but have not been confirmed by a new act in over six years. They do not count as active directors.
  • LYNX PHARMA
    Administrateur unique
    State Gazette act 20335987 (03-08-2020)
    Not recently confirmed
    last confirmed in an act from 2020
  • LYNX PHARMA SPRLLegal entity
    Director
    State Gazette act 18046596 (16-03-2018)
    Not recently confirmed
    last confirmed in an act from 2018
    2 events
    • 16-03-2018 Appointed· Director
    • 16-03-2018 Appointed· Managing director
  • M. Jérémie URBAIN
    Director
    State Gazette act 17174099 (12-12-2017)
    Not recently confirmed
    last confirmed in an act from 2017
    2 events
    • 12-12-2017 Resigned· Director
    • 12-12-2017 Appointed· Director
  • M. Michel URBAIN
    Director
    State Gazette act 17174099 (12-12-2017)
    Not recently confirmed
    last confirmed in an act from 2017
    2 events
    • 12-12-2017 Resigned· Director
    • 12-12-2017 Appointed· Director
Permanent representatives (1)
These people represent a legal-person director (a management company, for instance). They hold no board mandate of their own and do not count as directors.
  • URBAIN Jérémie Alexandre
    Représentant de lynx pharma
    State Gazette act 20335987 (03-08-2020)
    Permanent representative
    03-08-2020 → present
Former directors (6)
  • Martine SUCKERS
    Director
    State Gazette act 23046585 (05-04-2023)
    Former
    05-04-2023 → 15-07-2024
    4 events
    • 15-07-2024 Resigned· Director
    • 15-07-2024 Resigned· Managing director
    • 05-04-2023 Appointed· Director
    • 05-04-2023 Appointed· Managing director
  • Lynx Pharma SrlLegal entity
    Administrator
    State Gazette act 23093417 (20-07-2023)
    Former
    - → 20-07-2023
  • URBAIN Michel
    Director
    State Gazette act 20335987 (03-08-2020)
    Former
    - → 03-08-2020
  • JUVEST SPRLLegal entity
    Director
    State Gazette act 17174099 (12-12-2017)
    Former
    12-12-2017 → 23-05-2019
    3 events
    • 23-05-2019 Resigned· Director
    • 12-12-2017 Resigned· Director
    • 12-12-2017 Appointed· Director
  • L'ARGUENON SPRLLegal entity
    Director
    State Gazette act 17174099 (12-12-2017)
    Former
    12-12-2017 → 23-05-2019
    3 events
    • 23-05-2019 Resigned· Director
    • 12-12-2017 Resigned· Director
    • 12-12-2017 Appointed· Director
  • Jérémie URBAIN
    Managing director
    State Gazette act 17175132 (13-12-2017)
    Former
    13-12-2017 → 16-03-2018
    4 events
    • 16-03-2018 Resigned· Director
    • 16-03-2018 Resigned· Managing director
    • 13-12-2017 Resigned· Managing director
    • 13-12-2017 Appointed· Managing director
Full appointment history from the Belgian State Gazette. Permanent representatives are shown for corporate directors.This list is read straight from this company's published acts, not from the officer register.

Statutory auditor

3 auditors
Statutory auditor IRE/IBR number Tenure
Pascale TytgatCurrent
Commissaire
 - 08-03-2019 → present
BST Reviseurs d'Entreprises
Commissaire
 - 10-03-2020 → 10-03-2020
ERNST & YOUNG REVISEURS D'ENTREPRISES
Commissaire
 - 24-10-2019 → 10-03-2020
Appointed statutory auditor from the Belgian State Gazette. The IRE/IBR number refers to the register of the Institute of Registered Auditors.

Insolvency mandates

No insolvency mandates (liquidators, administrators) on record for this company.

Legal Structure

NACE primary Groothandel in farmaceutische en medische artikelen(46460)
Legal form Public limited company(014)
Incorporation20-09-2013
StatusActive
Postal code1050

Structure & network

Locations & real estate

Registered office

on the map · from the address register
exact location from the address register On OpenStreetMap
268 companies at this address See who is registered here

Establishment units

1 location
SERB
Louizalaan 480, 1050 ElseneVervaardiging van overige farmaceutische producten
since 20132.235.348.469
Physical sites registered in the Crossroads Bank for Enterprises (CBE).
Parcels1
Ground area2,791 m²
Buildings1
Building footprint1,235 m²
Volume (LiDAR)89,309 m³
Tallest building106.8 m · ±30 fl.

Real-estate footprint

Source: CBE × cadastre · address linking

Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.

Brussels 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
21822R0227/00V003 Brussels 2,791 m² 1 · 1,235 m² 106.8 m · 30 fl.
Methodology
via registered seat: 1
1 of 1 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Publications

Lifecycle & Insolvency Signals

No insolvency signals in the Belgian State Gazette

Belgisch Staatsblad · acts

16 acts
Capital history · 3
03-08-2020
v3.2
31-01-2019
v3.2
04-12-2017
v3.2
All acts · 16 updated 2 years ago
2024
15-07-2024 2 directors appointed, 2 resigning Director changes
  • Marc BUCHET, Bestuurder
  • Marc BUCHET, Gedelegeerd bestuurder
  • Martine SUCKERS, Bestuurder
  • Martine SUCKERS, Gedelegeerd bestuurder
Summary: v3.2
2023
20-07-2023 2 directors appointed, 1 resigning Director changes
  • Antoine Bernasconi, Administrator
  • Bich Pham Huy, Administrator
  • Lynx Pharma Srl, Administrator
Summary: v3.2
05-04-2023 2 directors appointed Director changes
  • Martine SUCKERS, Bestuurder
  • Martine SUCKERS, Gedelegeerd bestuurder
Summary: v3.2
2022
08-07-2022 Pascale Tytgat appointed as commissaire Director changes
  • Pascale Tytgat, Commissaire
Summary: v3.2
2020
03-08-2020 Capital increase of €12,484,521 to €33,097,569 Capital & shares
  • €20.613.048 → €33.097.569
  • Inbreng in natura · Apport en nature
Summary: v3.2
10-03-2020 1 director appointed, 1 resigning Director changes
  • BST Reviseurs d'Entreprises, Commissaire
  • Ernst & Young Reviseurs d'Entreprises, Commissaire
Summary: v3.2
2019
24-10-2019 1 director appointed, 1 resigning Director changes
  • ERNST & YOUNG REVISEURS D'ENTREPRISES, Commissaire
  • BST REVISEURS D'ENTREPRISES, Commissaire
Summary: v3.2
23-05-2019 2 resigning Director changes
  • L'ARGUENON SPRL, Bestuurder
  • JUVEST SPRL, Bestuurder
Summary: v3.2
08-03-2019 Pascale Tytgat appointed as commissaire Director changes
  • Pascale Tytgat, Commissaire
Summary: v3.2
31-01-2019 Capital increase of €8,823,573 to €20,613,048 Capital & shares
  • €11.789.475 → €20.613.048
  • Inbreng in natura · Apport en nature
Summary: v3.2
2018
22-03-2018 Articles of association amended Statutes amendment
Summary: v3.2
16-03-2018 2 directors appointed, 2 resigning Director changes
  • LYNX PHARMA SPRL, Bestuurder
  • LYNX PHARMA SPRL, Gedelegeerd bestuurder
  • Jérémie URBAIN, Bestuurder
  • Jérémie URBAIN, Gedelegeerd bestuurder
Summary: v3.2
2017
13-12-2017 1 director appointed, 1 resigning Director changes
  • Jérémie URBAIN, Gedelegeerd bestuurder
  • Jérémie URBAIN, Gedelegeerd bestuurder
Summary: v3.2
12-12-2017 4 directors appointed, 4 resigning Director changes
  • M. Jérémie URBAIN, Bestuurder
  • M. Michel URBAIN, Bestuurder
  • JUVEST SPRL, Bestuurder
  • L'ARGUENON SPRL, Bestuurder
  • M. Jérémie URBAIN, Bestuurder
  • M. Michel URBAIN, Bestuurder
  • JUVEST SPRL, Bestuurder
  • L'ARGUENON SPRL, Bestuurder
Summary: v3.2
04-12-2017 Transaction in capital or shares Capital & shares
Summary: v3.2
22-11-2017 Articles of association amended Statutes amendment
Summary: v3.2

Analysis

Credit advice

verdict per customer and amount

Should this customer buy amount X on invoice? Enter the amount and payment terms, you get an instant GREEN/AMBER/RED verdict, with a suggested ceiling and concrete conditions.

Based on official sources (NBB, CBE, State Gazette). Indicative, not credit advice.

Similar

Similar companies

Same sector and region
We hold no filed accounts for this company, so a size comparison is not possible. These companies share only the sector and the region. We hold annual accounts for 196 of the 1,895 companies in this sector.

Company registry

Company registry (CBE)

Crossroads Bank
Activities
Groothandel in farmaceutische producten46460Groothandel in farmaceutische en medische artikelen46460Vervaardiging van geneesmiddelen21201Vervaardiging van geneesmiddelen21201
Primary activity highlighted.
Names & trade names
Legal nameFR SERB
Registered office
Louizalaan 480
1050 Elsene, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.